MDXG
MiMedx Group Inc
NASDAQ: MDXG · HEALTHCARE · BIOTECHNOLOGY
$3.36
+8.91% today
Updated 2026-04-30
Market cap
$458.33M
P/E ratio
9.64
P/S ratio
1.10x
EPS (TTM)
$0.32
Dividend yield
—
52W range
$3 – $8
Volume
1.4M
MiMedx Group Inc (MDXG) Financial statements
SEC filings — annual and quarterly data.
Profit margin
11.60%
Operating margin
17.80%
ROE
21.60%
ROA
13.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | — | $-16738.00 | — | — | — |
| 2007 | — | $-38860.00 | — | — | — |
| 2008 | — | $-17.37M | — | — | — |
| 2009 | — | $-11.92M | — | — | — |
| 2010 | $788874.00 | $-11.42M | -118.04% | -1,335.15% | -1,447.60% |
| 2011 | $7.76M | $-10.19M | 59.35% | -125.78% | -131.36% |
| 2012 | $27.05M | $-7.66M | 80.82% | -7.36% | -28.32% |
| 2013 | $59.18M | $-4.11M | 84.24% | -4.46% | -6.95% |
| 2014 | $118.22M | $6.22M | 89.29% | 6.01% | 5.26% |
| 2015 | $187.30M | $29.45M | 89.21% | 13.01% | 15.72% |
| 2016 | $245.01M | $11.97M | 86.77% | 0.36% | 4.89% |
| 2017 | $321.14M | $64.73M | 89.03% | 14.39% | 20.16% |
| 2018 | $359.11M | $-29.98M | 89.87% | -1.09% | -8.35% |
| 2019 | $359.11M | $-29.98M | 89.87% | -1.09% | -8.35% |
| 2020 | $248.23M | $-49.28M | 84.16% | -18.29% | -19.85% |
| 2021 | $242.02M | $-12.30M | 83.63% | -2.91% | -5.08% |
| 2022 | $267.84M | $-30.20M | 81.96% | -5.50% | -11.27% |
| 2023 | $321.48M | $67.44M | 83.01% | 11.55% | 20.98% |
| 2024 | $348.88M | $42.42M | 82.78% | 16.87% | 12.16% |
| 2025 | $418.63M | $48.58M | 82.56% | 15.26% | 11.60% |